Background and Purpose—Stroke mortality has been declining since the early 20th century.
The reasons for this are not completely understood, although the decline is welcome. As a …

Background Long-term follow-up of randomised trials of aspirin in prevention of vascular
events showed that daily aspirin reduced the incidence of colorectal cancer and several …

Clinical guidelines for prophylactic aspirin use currently only consider the cardiovascular
benefits of aspirin, weighed against the potential harm from aspirin-induced bleeding. Daily …

Background Accumulating evidence supports an effect of aspirin in reducing overall cancer
incidence and mortality in the general population. We reviewed current data and assessed …

Background Randomised trials have shown that aspirin reduces the short-term risk of
recurrent colorectal adenomas in patients with a history of adenomas or cancer, but large …

After more than a century, aspirin remains one of the most commonly used drugs in western
medicine. Although mainly used for its anti-thrombotic, anti-pyretic, and analgesic properties …

Background Aspirin has been associated to a reduced risk of colorectal and possibly of a
few other common cancers. Methods To provide an up-to-date quantification of this …

Platelets serve as “first responders” during normal wounding and homeostasis. Arising from
bone marrow stem cell lineage megakaryocytes, anucleate platelets can influence …

The existing epidemiologic literature was comprehensively reviewed to retrieve all
epidemiologic studies (case control and cohort studies) that examined exposure to …

The emerging photoluminescent carbon-based nanomaterials are promising in various
fields besides cell imaging and carrier transport. Carbon nanomaterials with specific …